Search Within

Ross Firestone

Formats
  1. Meeting Abstract (30)
  2. Journal Article (8)
  3. Review (3)
  4. Correspondence (1)
  5. Editorial (1)
  6. Research Letter (1)
Groups
  1. GME, Medicine (44)
  2. Graduate Medical Education (44)
  3. Hematology-Oncology Fellows (44)
  4. Weinberg Fellows (44)
  5. Department of Medicine (42)
  6. Hematologic Malignancies, Division of (41)

More Groups

People
  1. Saad Usmani (41)
  2. Kylee Maclachlan (37)
  3. Malin Hultcrantz (37)
  4. Sham Mailankody (37)
  5. Alexander Lesokhin (36)
  6. Sergio Giralt (36)

More People

Years
  1. 2025 (8)
  2. 2024 (25)
  3. 2023 (11)
Publications
  1. Blood (17)
  2. Clinical Lymphoma, Myeloma and Leukemia (13)
  3. Blood Advances (5)
  4. Blood Cancer Journal (2)
  5. Journal of Clinical Oncology (2)
  6. Blood Cancer Discovery (1)

More Publications

Publishers
  1. American Society of Hematology (23)
  2. Elsevier Inc. (14)
  3. American Association for Cancer Research (2)
  4. American Society of Clinical Oncology (2)
  5. Nature Publishing Group (2)
  6. Churchill Livingstone (1)

Results (44)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Unsupervised graph-based visualization of variational autoencoder latent spaces reveals hidden multiple myeloma subtypes
    Meeting Abstract

    Simhal, A. K.; Elkin, R.; Firestone, R. S.; Oh, J. H.; Deasy, J. O.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma
    Journal Article

    Adegbite, B.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: A real-world experience
    Journal Article

    Hultcrantz, M.; Derkach, A.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; more...
    Blood Neoplasia (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma
    Correspondence

    Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
    Research Letter

    Tan, C. R.; Wang, A.; Nemirovsky, D.; Derkach, A.; Shekarkhand, T.; Hamadeh, I.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • More than myeloma: The trouble with “normal” plasma cells
    Editorial

    Firestone, R. S.; Maura, F.
    Blood (2025)

    Fulltext@MSK | Save
  • High WEE1 expression is independently linked to poor survival in multiple myeloma
    Journal Article

    Simhal, A. K.; Firestone, R. S.; Oh, J. H.; Avutu, V.; Norton, L.; Hultcrantz, M.; Usmani, S. Z.; Maclachlan, K. H.; Deasy, J. O.
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rajeeve, S.; Costa, B. A.; Jurgens, E. M.; Nishimura, N.; Farzana, T.; Firestone, R. S.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save